Anaconda Biomed secures $56 million financing led by Omega Funds, with support from new and existing investors. The funds will aid product development and clinical studies for its thrombectomy catheters.
Amount Raised
$56 Million
Round Type
Venture
BarcelonaBiotechnologyHealth CareMedicalMedical DeviceInvestors
Description
Anaconda Biomed has announced the closing of a $56 million financing round to support product development and clinical work related to its novel thrombectomy catheters. This financing round was led by Omega Funds and includes participation from various new and existing investors. The funds will be utilized for the ongoing ATHENA pivotal IDE study, which evaluates the safety and performance of the ANA Funnel Catheter. CEO Trent Reutiman emphasized the significance of this funding in advancing treatments for ischemic stroke.
Quick answer
Anaconda BioMed raised $56 Million in a funding round, dated September 23, 2026. Investors: Spain’s Co-investment fund, Spain’s Co Investment Fund (Foco), Asabys (Sabadell Asabys Ii), Ysios Capital, Cdti and Omega Funds. Anaconda BioMed is based in Barcelona, Catalonia, Spain.
- How much did Anaconda BioMed raise?
- Anaconda BioMed raised $56 Million in a funding round on September 23, 2026.
- Who invested in Anaconda BioMed?
- Spain’s Co-investment fund, Spain’s Co Investment Fund (Foco), Asabys (Sabadell Asabys Ii), Ysios Capital, Cdti and Omega Funds are named as investors in this round.
- What does Anaconda BioMed do?
- Anaconda Biomed is an innovative medical technology company dedicated to developing next-generation thrombectomy systems for the treatment of ischemic stroke.
- Where is Anaconda BioMed based and how big is it?
- Anaconda BioMed is based in Barcelona, Catalonia, Spain. Fundz records about 34 employees.
- Who are the decision-makers at Anaconda BioMed?
- Fundz holds 2 contacts at Anaconda BioMed, including the Director Research Development Engineering. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as Anaconda BioMed that raised within 45 days of this round, from Fundz verified event records.
- Laza Medical raised $160M (Series B) on November 4, 2026.
- Picard Medical raised $1.2M (Funding Round) on November 3, 2026.
- StimCardio raised $30M (Series A) on October 29, 2026.
- Impress raised $45M (Debt Financing) on October 27, 2026.
- adsilico raised $13M (Series A) on October 26, 2026.
- Parasol Medtech raised $2.8M (Pre-Seed) on October 26, 2026.
Who to call at Anaconda BioMed, and when
A new round usually means Anaconda BioMed is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Anaconda BioMed raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Anaconda BioMed, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Anaconda BioMed. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Anaconda BioMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Anaconda BioMed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.